Skip to main content

Advertisement

Log in

Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

To investigate the efficacy of our treatment of infantile hemangioma (IH)s retrospectively presenting as disfiguring or functionally threatening lesions.

Materials and methods

25 infants with IH treated with long-pulsed dye laser or laser with or without propranolol. Tumor fading after treatment was evaluated using both color and size rating scales, before, during and after treatment.

Results

6 infants were treated by laser, 11, oral propranolol and 8 using both treatments. Each treatment was effective for most IH with a median treatment duration of 7.7 months for laser, and 13.3 months for the latter two. Combination therapy was the most effective in both color-fading and size reduction by the 3rd month. Laser alone was most effective in color-fading with almost complete disappearance of most tumors. Oral propranolol to the three site-specific IHs was effective with disappearance of tumors. There were no apparent side effects related to laser treatment, but one infant suffered from allergy and another from bronchial asthma due to propranolol medication.

Conclusions

Most IHs discolored and regressed considerably with these treatments, including complete disappearance of the three functionally threatening lesions. This combined approach is quite useful for accelerating tumor regression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Keller RG, Patel KG (2015) Evidence-based medicine in the treatment of infantile hemangiomas. Fac Plast Surg Clin North Am 23:373–392. doi:10.1016/j.fsc.2015.04.009

    Article  Google Scholar 

  2. Craiglow BG, Antaya RJ (2013) Management of infantile hemangiomas: current and potential pharmacotherapeutic approaches. Paediatr Drugs 15:133–138. doi:10.1007/s40272-013-0008-6

    Article  PubMed  Google Scholar 

  3. Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P (2013) The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 52:1140–1146. doi:10.1111/j.1365-4632.2012.05795

    Article  CAS  PubMed  Google Scholar 

  4. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R (2002) Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 360:521–527

    Article  PubMed  Google Scholar 

  5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651. doi:10.1056/NEJMc0708819

    Article  PubMed  Google Scholar 

  6. Kwon SH, Choi JW, Byun SY, Kim BR, Park KC, Youn SW, Huh CH, Na JI (2014) Effect of early long-pulse pulsed dye laser treatment in infantile hemangiomas. Dermatol Surg 40:405–411. doi:10.1111/dsu.12451

    Article  CAS  PubMed  Google Scholar 

  7. Enjolras O, Riche MC, Merland JJ, Escande JP (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498

    CAS  PubMed  Google Scholar 

  8. Storch CH, Hoeger PH (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269–274. doi:10.1111/j.1365-2133.2010.09848.x

    Article  CAS  PubMed  Google Scholar 

  9. Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L, MacLellan-Tobert S, Mancini AJ, Metry D, Puttgen KB, Seefeldt M, Sidbury R, Ward KM, Blei F, Baselga E, Cassidy L, Darrow DH, Joachim S, Kwon EK, Martin K, Perkins J, Siegel DH, Boucek RJ, Frieden IJ (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128–140. doi:10.1542/peds.2012-1691

    Article  PubMed Central  Google Scholar 

  10. Reddy KK, Blei F, Brauer JA, Waner M, Anolik R, Bernstein L, Brightman L, Hale E, Karen J, Weiss E, Geronemus RG (2013) Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 39:923–933. doi:10.1111/dsu.12158

    Article  CAS  PubMed  Google Scholar 

  11. Rodríguez-Ruiz M, Tellado MG, Del Pozo Losada J (2016) Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma. An Pediatr. 84:92–96. doi:10.1016/j.anpedi.2015.04.007

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shigeyuki Furuta or Hiroaki Kitagawa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furuta, S., Sato, H., Tsuji, S. et al. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report. Pediatr Surg Int 32, 857–862 (2016). https://doi.org/10.1007/s00383-016-3942-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-016-3942-x

Keywords

Navigation